ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer ...
Improved radiographic progression-free survival (rPFS) regardless of disease volume or metastatic presentation achieved with Pluvicto plus standard of care (ARPI + ADT) in PSMAdditionConsistent ...
Primary results from the Phase II ARACOG (AFT-47) trial, a head-to-head randomized trial conducted by Alliance Foundation Trials LLC, showed that patients treated with NUBEQA® (darolutamide; n=55) ...
Like this article? Keep independent journalism alive. Support HuffPost. New data suggest that GLP-1 medication could reduce metastatic progression in certain cancers, according to findings that will ...
New findings to be presented at ASCO 2026 suggest GLP-1 medicines may help reduce cancer progression, although experts say ...
Immunome, Inc. , a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced detailed efficacy and safety results from RINGSIDE, the ...
Partners Summit Therapeutics and Akeso are expected to steal the show at the American Society of Clinical Oncology’s annual ...
An innovative blood test could detect hidden signs of cancer spreading earlier than CT scans and help adjust treatments in a timely manner.
Plus, what to do instead.
Detailed price information for Precision Drilling Corp (PDS-N) from The Globe and Mail including charting and trades.
Recognising the early warning signs for breast cancer isn’t just feeling for lumps. Here’s everything medical experts want ...
Novartis has a more mature AI narrative than many industrial or healthcare peers. The company says it has already developed more than 100 AI use cases across R&D, operations, and commercial activity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results